231 related articles for article (PubMed ID: 22829011)
1. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
2. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
3. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
[TBL] [Abstract][Full Text] [Related]
4. Identification of a SUFU germline mutation in a family with Gorlin syndrome.
Pastorino L; Ghiorzo P; Nasti S; Battistuzzi L; Cusano R; Marzocchi C; Garrè ML; Clementi M; Scarrà GB
Am J Med Genet A; 2009 Jul; 149A(7):1539-43. PubMed ID: 19533801
[TBL] [Abstract][Full Text] [Related]
5. A new germline mutation of the PTCH gene in a Japanese patient with nevoid basal cell carcinoma syndrome associated with meningioma.
Tate G; Li M; Suzuki T; Mitsuya T
Jpn J Clin Oncol; 2003 Jan; 33(1):47-50. PubMed ID: 12604725
[TBL] [Abstract][Full Text] [Related]
6. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
7. Myogenic tumors in nevoid Basal cell carcinoma syndrome.
Hettmer S; Teot LA; Kozakewich H; Werger AM; Davies KJ; Fletcher CD; Grier HE; Rodriguez-Galindo C; Wagers AJ
J Pediatr Hematol Oncol; 2015 Mar; 37(2):147-9. PubMed ID: 24517962
[TBL] [Abstract][Full Text] [Related]
8. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.
Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review.
Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S
Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294
[TBL] [Abstract][Full Text] [Related]
10. Novel PTCH1 mutations in Japanese Nevoid basal cell carcinoma syndrome patients: two familial and three sporadic cases including the first Japanese patient with medulloblastoma.
Fujii M; Noguchi K; Urade M; Muraki Y; Moridera K; Kishimoto H; Hashimoto-Tamaoki T; Nakano Y
J Hum Genet; 2011 Apr; 56(4):277-83. PubMed ID: 21368767
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
[TBL] [Abstract][Full Text] [Related]
12. First evidence of genotype-phenotype correlations in Gorlin syndrome.
Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT
J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197
[TBL] [Abstract][Full Text] [Related]
13. Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.
Fujii K; Ohashi H; Suzuki M; Hatsuse H; Shiohama T; Uchikawa H; Miyashita T
Fam Cancer; 2013 Dec; 12(4):611-4. PubMed ID: 23479190
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome.
Suzuki M; Nagao K; Hatsuse H; Sasaki R; Saito K; Fujii K; Miyashita T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):348-53. PubMed ID: 23953420
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.
Pan S; Dong Q; Sun LS; Li TJ
Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110
[TBL] [Abstract][Full Text] [Related]
16.
Ponti G; Manfredini M; Pastorino L; Maccaferri M; Tomasi A; Pellacani G
Anticancer Res; 2018 Jan; 38(1):471-476. PubMed ID: 29277811
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous PTCH1 Mutations Impact the Bone Metabolism in Patients With Nevoid Basal Cell Carcinoma Syndrome Likely by Regulating SPARC Expression.
Hong Y; Zhang J; Zhang H; Li X; Qu J; Zhai J; Zhang L; Chen F; Li T
J Bone Miner Res; 2016 Jul; 31(7):1413-28. PubMed ID: 26890308
[TBL] [Abstract][Full Text] [Related]
18. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
Sun LS; Li XF; Li TJ
J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
[TBL] [Abstract][Full Text] [Related]
19. Multiple tumor types including leiomyoma and Wilms tumor in a patient with Gorlin syndrome due to 9q22.3 microdeletion encompassing the PTCH1 and FANC-C loci.
Garavelli L; Piemontese MR; Cavazza A; Rosato S; Wischmeijer A; Gelmini C; Albertini E; Albertini G; Forzano F; Franchi F; Carella M; Zelante L; Superti-Furga A
Am J Med Genet A; 2013 Nov; 161A(11):2894-901. PubMed ID: 24124115
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
